BioStorage Opens New Biorepository

BioStorage Technologies has opened its new 60,000-sq.-ft. biorepository facility in Indianapolis, IN. The facility is dedicated to the preparation, storage and cold-chain transport of human biological samples for a variety of customers, including academic centers, CROs, donor programs and biotechnology companies.

“BioStorage Technologies is committed to its investment in comprehensive sample management solutions, and this new facility provides the company with the infrastructure needed to support our continued growth and expanded services,” said Greg Swanberg, chief executive officer of BioStorage Technologies.

The expansion allows BioStorage to offer sample preparation services, including automated liquid handling technology for high-throughput DNA and RNA extraction and verification. Once samples are processed, aliquots of blood and/or DNA products can be retrieved and scheduled for transport to research testing sites using the company’s tracking and inventory management system, ISISS.

Storage options available at the facility include: automated carousel controlled-room temperature storage at 15ºC to 27ºC, bulk sample storage at 15ºC to 27ºC, walk-in cold sample storage -20ºC to 5ºC, ultra-low temperature storage -70°C to -80°C, and -190ºC vapor phase liquid nitrogen. BioStorage Technologies maintains FDA 21 CFR Part 11 validated technology systems and adheres to FDA regulations, as well as U.S. Department of Transportation and International Air Transport Association guidelines.